Elimination of post-transplant donor-specific HLA antibodies with bortezomib.

Clinical transplants

Volumn , Issue , 2008, Pages 229-239

  Idica, A ^a   Kaneku, H ^a   Everly, M J ^a   Trivedi, H L ^a   Feroz, A ^a   Vanikar, A V ^a   Shankar, V ^a   Trivedi, V B ^a   Modi, P R ^a   Khemchandani, S I ^a   Dave, S D ^a   Terasaki, P I ^a  

^a One Lambda Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BORONIC ACID DERIVATIVE; BORTEZOMIB; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; PROTEASOME; PROTEINASE INHIBITOR; PYRAZINE DERIVATIVE;

ADULT; ALLOTRANSPLANTATION; ARTICLE; BLOOD; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GRAFT REJECTION; HUMAN; IMMUNOLOGY; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; MIDDLE AGED; PLASMA CELL; PLASMAPHERESIS; TIME; TREATMENT OUTCOME;

ADULT; ANTIBODIES; BORONIC ACIDS; GRAFT REJECTION; HLA ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PLASMA CELLS; PLASMAPHERESIS; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PYRAZINES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 68049119098     PISSN: 08909016     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)